← All investors
Bioeconomy Capital
About
Bioeconomy Capital is an early-stage firm led by managing directors Rob Carlson and Rik Wehbring, backing companies that build infrastructure for the biotechnology economy. It typically invests $100,000 to $5m, with a sweet spot around $1.5m. Prior investments include Zymergen, Synthace, RoosterBio and Arzeda.
Industries
Industrial / CVC
Stage focus
SeedSeries ASeries B
Raising from Bioeconomy Capital?
I've worked with founders across the industrial stack. If Bioeconomy Capital is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.
Talk to Dan